» Articles » PMID: 38659567

A Case of Pheochromocytoma With Coagulation Necrosis Due to Hypertensive Crisis Aggravated by Contrast-Enhanced CT Scan and Negative 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy

Overview
Journal Cureus
Date 2024 Apr 25
PMID 38659567
Authors
Affiliations
Soon will be listed here.
Abstract

I-metaiodobenzylguanidine (I-MIBG) scintigraphy is a highly sensitive and specific imaging test for the diagnosis of pheochromocytoma. Typical pheochromocytomas are positive on I-MIBG scintigraphy; however, cases of paragangliomas eliciting negative results have been reported. We encountered a case of hypertensive crisis resulting in extensive coagulative necrosis of a pheochromocytoma and negative findings on I-MIBG scintigraphy. A 50-year-old Japanese female presented with an acute onset of vomiting, epigastralgia, and abdominal pain. Immediately after contrast-enhanced CT, the patient developed respiratory failure and was intubated. The CT scan revealed a 5-cm left adrenal mass, and a pheochromocytoma crisis was suspected. The patient's condition stabilized following phentolamine administration. Regarding the assessment for pheochromocytoma, plasma metanephrine levels were not markedly increased, and I-MIBG scintigraphy was negative. However, a histological examination of the left adrenal mass revealed extensive coagulative necrosis of the entire adrenal mass, comprising trabecular and alveolar growth of large polygonal cells that were immunopositive for chromogranin A/synaptophysin, thereby suggesting a diagnosis of pheochromocytoma. There have been three reported cases of I-MIBG scintigraphy-negative pheochromocytomas because of pure avascular necrosis without hemorrhage or rupture. To the best of our knowledge, this is the first reported case of massive tumor necrosis due to hypertensive crisis exacerbated after contrast-enhanced CT imaging. In conclusion, pheochromocytoma cannot be ruled out even with negative findings on I-MIBG scintigraphy. Accordingly, clinical judgment must be made based on a comprehensive assessment of the clinical course and pathological diagnosis, especially for cases involving a hypertensive crisis.

References
1.
Lenders J, Eisenhofer G . Update on Modern Management of Pheochromocytoma and Paraganglioma. Endocrinol Metab (Seoul). 2017; 32(2):152-161. PMC: 5503859. DOI: 10.3803/EnM.2017.32.2.152. View

2.
Kolby L, Bernhardt P, Levin-Jakobsen A, Johanson V, Wangberg B, Ahlman H . Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters. Br J Cancer. 2003; 89(7):1383-8. PMC: 2394326. DOI: 10.1038/sj.bjc.6601276. View

3.
Bomanji J, Levison D, Flatman W, Horne T, Bouloux P, Ross G . Uptake of iodine-123 MIBG by pheochromocytomas, paragangliomas, and neuroblastomas: a histopathological comparison. J Nucl Med. 1987; 28(6):973-8. View

4.
King K, Chen C, Alexopoulos D, Whatley M, Reynolds J, Patronas N . Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. J Clin Endocrinol Metab. 2011; 96(9):2779-85. PMC: 3167674. DOI: 10.1210/jc.2011-0333. View

5.
Tsuji A, Shimomura O, Tomiguchi S, Kojima A, Hara M, Kinoshita R . [Diagnosis of pheochromocytoma using 131I-MIBG scintigraphy]. Kaku Igaku. 1993; 30(3):241-7. View